Daré Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-30.16	-30.95	-38.7	-27.41	-15.05	-16.74	-11.5	-0.67	-39.59	-23.34	Upgrade
Depreciation & Amortization	0.09	0.05	-0.07	-0.12	-0.02	0.01	0	0	0.19	0.13	Upgrade
Share-Based Compensation	2.53	2.16	1.6	0.74	0.46	0.14	0.02	0.01	2.38	0.89	Upgrade
Other Operating Activities	-11.32	10.65	8.4	1.54	0.5	6.32	8.95	0.29	5.11	3.27	Upgrade
Operating Cash Flow	-38.86	-18.09	-28.76	-25.23	-13.32	-10.27	-2.54	-0.37	-31.92	-19.06	Upgrade
Capital Expenditures	-0.63	-0.06	-0.01	-0.02	0	-0.01	0	0	-0.25	-0.19	Upgrade
Acquisitions	0	0	0	0	6.14	-0.51	9.92	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-0.23	-	Upgrade
Investing Cash Flow	-0.63	-0.06	-0.01	-0.02	6.14	-0.52	9.92	0	-0.48	-0.19	Upgrade
Share Issuance / Repurchase	10.65	1.34	75.85	24.76	5.15	10.11	0	0	39.81	60	Upgrade
Debt Issued / Paid	0.27	0	0	0.37	0	0	0.16	0.2	17.32	4.93	Upgrade
Other Financing Activities	4.72	-	-	-	-	0	-	-	-	-	Upgrade
Financing Cash Flow	15.64	1.34	75.85	25.13	5.15	10.11	0.16	0.2	57.13	64.93	Upgrade
Exchange Rate Effect	-0.01	-0.2	-0.06	0.01	-0.01	-0.08	-0.02	0	0	0	Upgrade
Net Cash Flow	-23.86	-17	47	-0.11	-2.03	-0.75	7.52	-0.17	24.73	45.69	Upgrade
Free Cash Flow	-39.49	-18.15	-28.78	-25.25	-13.32	-10.28	-2.54	-0.37	-32.17	-19.25	Upgrade
Free Cash Flow Margin	-1406.26%	-181.51%	-	-	-	-	-	-	-	-24057.50%	Upgrade
Free Cash Flow Per Share	-0.45	-0.21	-0.47	-0.84	-0.85	-0.96	-0.79	-0.45	-12.65	-13.23	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).